Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CEA Antikörper

Der Maus Monoklonal anti-CEA Antikörper wird verwendet zum Nachweis von CEA in Proben von Human. Er wurde validiert für IHC (p).
Produktnummer ABIN3026748
642,40 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für CEA Antikörper (ABIN3026748)

Target

Alle CEA Antikörper anzeigen
CEA (Carcinoembryonic Antigen Gene Family (CEA))

Reaktivität

  • 202
  • 11
  • 3
  • 3
  • 1
Human

Wirt

  • 126
  • 87
  • 2
  • 1
  • 1
Maus

Klonalität

  • 164
  • 48
  • 4
Monoklonal

Konjugat

  • 100
  • 18
  • 9
  • 6
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CEA Antikörper ist unkonjugiert

Applikation

  • 90
  • 75
  • 47
  • 42
  • 31
  • 28
  • 27
  • 25
  • 17
  • 16
  • 13
  • 9
  • 5
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Güteklasse

Carrier-free

Klon

SPM541
  • Verwendungszweck

    CEA Antibody / CEACAM5 (azide and preservative free)

    Produktmerkmale

    This antibody recognizes proteins of 80-200 kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70 % are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

    Aufreinigung

    Protein G affinity chromatography

    Immunogen

    Human colon carcinoma extract was used as the immunogen for this CEA antibody.

    Isotyp

    IgG1, kappa
  • Applikationshinweise

    The optimal dilution of the CEA antibody for each application should be determined by the researcher.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Tris with 1 mM EDTA, pH 9, for 10-20 min followed by cooling at RT for 20 minutes.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    Konservierungsmittel

    Azide free

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store the CEA antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
  • Target

    CEA (Carcinoembryonic Antigen Gene Family (CEA))

    Andere Bezeichnung

    CEA

    Hintergrund

    This antibody recognizes proteins of 80-200 kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70 % are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

    UniProt

    P06731
Sie sind hier:
Chat with us!